Oncologists: More Advanced Cancers, Current Tests Not Catching Cancer Recurrence Early Enough
Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren't effective enough.
Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren't effective enough.
Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.
Thermo Fisher has launched the 1500 Series Class II, Type A2 Biological Safety Cabinet, enhancing lab safety and operational efficiency.
Nordic Bioscience's PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a way to assess liver fibrosis.